Previous Space Investment News

As the tough 2020—with its tragic loss of human life to COVID-19 and economic disruptions during the fight with the virus—comes to a close, we are entering 2021 on a brighter note following recent positive vaccine news.

This investor pitch event drove attendance from marquee venture firms and corporate investors and included an exciting set of presentations across many industry verticals.

What stood out for us was the presenters’ commentary on current capital access trends and investment focus areas as well as the value added of public-private partnerships.

The first-ever commercial airlock—self-funded, built, and operated by Nanoracks— is expected to increase capabilities for both space-based R&D as well as station operations.

Despite the “new normal” of the pandemic and its effects on our daily lives, the year has brought some very solid successes in the space industry.

Yesterday, Redwire announced the acquisition of Made In Space, Inc., the leading developer of in-space manufacturing technologies.

Last week, Made In Space received an award from NASA supporting two new proposals focused on space-based manufacturing.

Researchers at the UCSD, together with Space Tango, received an award of nearly $5 million from NASA to develop a new dedicated stem cell research laboratory on the ISS.

NASA’s award will support a series of flight projects to the ISS for LambdaVision, together with Space Tango, to continue to examine the production of the retinal implant in microgravity.

Orbitfab and Orbital Sidekick—both who have conducted research onboard the ISS National Lab—have received additional funding for future endeavours.

The International Space Station (ISS) U.S. National Laboratory had an opportunity to attend the fifth annual SmallSat Symposium, held in Silicon Valley last week.

Last week, a type of microscopic worm that kills crop-eating insects rocketed to the International Space Station U.S. National Laboratory for an agricultural biocontrol experiment in space.

Today, a team of investigators from Merck Research Laboratories published results in the journal Nature Microgravity from their crystallization research.

Last night, the International Space Station U.S. National Laboratory and Boeing announced the 2019 awardees of their annual “Technology in Space Prize” competition.

Exposure to space-based research through the MassChallenge accelerator program is how we took our research to a whole new level that we hadn’t even thought about: space.

Entrepreneurs have a different way of looking at things. With an “anything is possible” mentality and the belief that there is limitless potential, entrepreneurs can take what might seem like a crazy idea and turn it into a reality.

Doing spaceflight research is a lot like being a pioneer in the wild West: it’s exciting, it’s adventurous, and it’s challenging. In space, you’re dealing with a totally new environment, novel equipment, and even different biology.

Since 2014, the International Space Station U.S. National Laboratory has partnered with The Boeing Company to sponsor the MassChallenge “Technology in Space Prize” to support entrepreneurial use of the ISS for innovative R&D.

CONFERS (the Consortium for Execution of Rendezvous and Servicing Operations) hosted its 2019 Global Satellite Servicing Forum last week with the International Space Station (ISS) U.S. National Laboratory in attendance.

Two high-tech companies have teamed up to develop the first 3D printer dedicated to manufacturing human tissue in the microgravity conditions of space.

The International Space Station (ISS) U.S. National Laboratory held its annual space-focused startup and investor networking event, Space Investment 2019, at the ISSRDC.

The purpose of this Request for Proposals (RFP) is to solicit project concepts that propose use of the ISS National Laboratory for investigations in the field of industrial biomedicine.

The purpose of this Request for Proposals is to solicit project concepts that propose use of the ISS National Laboratory for investigations in advanced materials science and engineering.

These sessions will highlight analyses and forecasts behind the excitement and optimism for  continued growth of a sustainable economy in low Earth orbit.

The 3D BioFabrication Facility (BFF) will enable cutting-edge biotechnology research is space.

SpaceX’s 18^th commercial resupply services mission to the ISS will include 17 private-sector research projects sponsored by the U.S. National Laboratory.

Sierra Nevada Corporation Chairwoman, Owner, and President Eren Ozmen will be a keynote speaker at the 8^th annual ISSRDC.

Pharmaceutical company AstraZeneca is going to space to try to address one of the biggest health challenges on Earth: Cancer.

Although the FEI Conference focuses on technological innovation, it also pushes you to consider the human over technology.

The demand for small satellites has grown significantly over the last several years due to miniaturization technologies and the availability of deployment from the ISS.

Industry data points from the Space Symposium were encouraging for the NewSpace sector, and we now look forward to further announcements and progress on SDA’s promising plans.

ZBLAN optical fibers produced onboard the ISS National Lab could lead to improvements in optical communications and  other scientific and commercial uses on Earth.

The third edition of NASA’s “International Space Station Benefits for Humanity” publication was released, summarizing benefits to life on Earth that have resulted from ISS activities.

Space-based studies could help researchers better understand the structure of LRRK2, which could help advance drug development for Parkinson’s.

Last week’s SmallSat Symposium provided the International Space Station (ISS) National Lab with an opportunity for discussions with a cross section of participants.

On the ISS National Lab, scientists are leveraging microgravity to produce valuable materials such as optical fibers—and soon even human tissues and organs—in orbit.

SlingShot, developed by SEOPS, LLC, will enable the deployment of small satellites from Cygnus after it completes its primary mission and departs the ISS.

The International Space Station U.S. National Laboratory has published its fiscal year 2018 results. FY18 was a record-breaking year for portfolio expansion and private-sector utilization of the ISS National Lab.

A growing number of commercial entities—from small startups to Fortune 500 companies—are leveraging the unique environment of the ISS for innovative technology and materials R&D not possible on the ground.

LambdaVision is aiming to use the microgravity environment on the International Space Station (ISS) to improve the manufacturing process for their retinal implant.

This past weekend, crew members onboard the International Space Station  worked on an investigation by Micro-gRx to validate the company’s “lab-on-a-chip” cell culturing system.

CONFERS (the Consortium for Execution of Rendezvous and Servicing Operations) hosted its 2018 Global Satellite Servicing Forum in Washington, D.C. last week.